Association between drug-related cutaneous adverse events and survival outcomes in patients treated with enfortumab vedotin
European Journal of Cancer · 2025
DOI: 10.1016/j.ejca.2025.115427 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Samy Belkaïd und 13 weiteren Autor:innen. Beteiligte Einrichtung: Dermatologie, Centre Léon Bérard, Lyon, France; Dermatologie, Hôpital Lyon Sud, Hospices Civils de Lyon, Oullins-Pierre-Bénite, France; Université Cl…. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Drug Eruptions, Immunoconjugates, Urologic Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dermatologie, Centre Léon Bérard, Lyon, France; Dermatologie, Hôpital Lyon Sud, Hospices Civils de Lyon, Oullins-Pierre-Bénite, France; Université Claude Bernard Lyon 1, Villeurbanne, France. Electronic address: samy.be…
- Dermatologie, Hôpital Lyon Sud, Hospices Civils de Lyon, Oullins-Pierre-Bénite, France; Université Claude Bernard Lyon 1, Villeurbanne, France.
- Direction de la Recherche Clinique et de l'Innovation, Centre Léon Bérard, Lyon, France.
- Dermatologie, Centre Léon Bérard, Lyon, France; Université Claude Bernard Lyon 1, Villeurbanne, France.
- Oncologie médicale, Centre Léon Bérard, Lyon, France.
- Dermatologie, Centre Léon Bérard, Lyon, France; Université Claude Bernard Lyon 1, Villeurbanne, France; Immunologie clinique et allergologie, Hôpital Lyon Sud, Hospices Civils de Lyon, Oullins-Pierre-Bénite, France.
Zitieren
APA
Belkaïd, S., Ribereau-Gayon, E., Chabaud, S., Anriot, J., Chalas, T., Fléchon, A., Boyle, H., Vinceneux, A., Bérard, F., You, B., Freyer, G., Darnis, S., Tartas, S., & Amini-Adle, M. (2025). Association between drug-related cutaneous adverse events and survival outcomes in patients treated with enfortumab vedotin. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.115427
Vancouver
Belkaïd S, Ribereau-Gayon E, Chabaud S, Anriot J, Chalas T, Fléchon A, et al. Association between drug-related cutaneous adverse events and survival outcomes in patients treated with enfortumab vedotin. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.115427
BibTeX
@article{Belkad2025,
author = {Belkaïd, Samy and Ribereau-Gayon, Emmanuel and Chabaud, Sylvie and Anriot, Julien and Chalas, Thibald and Fléchon, Aude and Boyle, Helen and Vinceneux, Armelle and Bérard, Frédéric and You, Benoît and Freyer, Gilles and Darnis, Sophie and Tartas, Sophie and Amini-Adle, Mona},
title = {Association between drug-related cutaneous adverse events and survival outcomes in patients treated with enfortumab vedotin},
journal = {European Journal of Cancer},
year = {2025},
doi = {10.1016/j.ejca.2025.115427}
}
EUVIMED